BusinessIndian B2B company Udaan protects $75m financing, valued at $1.8 b by The Tamesis Udaan has actually increased $75 million from existing capitalists Lightspeed Endeavor Allies and M&G Prudential. Post Views: 82 Share this Facebook X Telegram Whatsapp Email Tags1.8b75mB2BfirmFundingIndiansecuresUdaanvaluedRelated Posts Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition April 27, 2026 10 Best Peptide Eye Creams to Lift, Firm, and Hydrate April 22, 2026 China AI Circuit Board Firm Raises $2bn in Year’s Top HK Listing April 21, 2026 The TamesisLeave a Reply Cancel replyYour email address will not be published. Save my name, email, and website in this browser for the next time I comment. Previous Story7MM Duchenne muscle dystrophy market to greater than dual by 2033 Next StoryHong Kong Crypto Unicorn Hashkey Protects $30 Million From Early PDD Financier Gaorong Latest from Blog Bank Of Japan’s Trigger Finger Is Getting Itchy by The Tamesis Adidas Revenues Rise 14% as Brand Celebrates Marathon Win by The Tamesis How to Buy an Antique Engagement Ring, Like Taylor Swift or Zendaya’s by The Tamesis Vogue Staffers Go Toe-to-Toe Over Chanel’s Freaky New Shoes by The Tamesis How Detroit’s Art Scene Is Ushering in a New Chapter for the City by The Tamesis Armani Group Sales Drop 2.8% in 2025 by The Tamesis Kylie Jenner and Timothée Chalamet Run It Back With Their Courtside Style by The Tamesis Olivia Rodrigo Gives Her Lover Girl Style a Vampy Twist by The Tamesis How I Finally Found a Comfortable (and Chic) Desk Chair by The Tamesis 5 Signs Your Skin Is Losing Collagen by The TamesisRelated Posts Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition April 27, 2026 10 Best Peptide Eye Creams to Lift, Firm, and Hydrate April 22, 2026 China AI Circuit Board Firm Raises $2bn in Year’s Top HK Listing April 21, 2026 Previous Story7MM Duchenne muscle dystrophy market to greater than dual by 2033 Next StoryHong Kong Crypto Unicorn Hashkey Protects $30 Million From Early PDD Financier Gaorong
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition April 27, 2026
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition April 27, 2026